Abstract
The aim of this six-centre, split-sample study was to compare ThinPrep fluid-based cytology to the conventional Papanicolaou smear. Six cytopathology laboratories and 35 gynaecologists participated. 5428 patients met the inclusion criteria (age > 18 years old, intact cervix, informed consent). Each cervical sample was used first to prepare a conventional Pap smear, then the sampling device was rinsed into a PreservCyt vial, and a ThinPrep slide was made. Screening of slide pairs was blinded (n = 5428). All non-negative concordant cases (n = 101), all non-concordant cases (n = 206), and a 5% random sample of concordant negative cases (n = 272) underwent review by one independent pathologist then by the panel of 6 investigators. Initial (blinded) screening results for ThinPrep and conventional smears were correlated. Initial diagnoses were correlated with consensus cytological diagnoses. Differences in disease detection were evaluated using McNemar’s test. On initial screening, 29% more ASCUS cases and 39% more low-grade squamous intraepithelial lesions (LSIL) and more severe lesions (LSIL+) were detected on the ThinPrep slides than on the conventional smears (P = 0.001), including 50% more LSIL and 18% more high-grade SIL (HSIL). The ASCUS:SIL ratio was lower for the ThinPrep method (115:132 = 0.87:1) than for the conventional smear method (89:94 = 0.95:1). The same trend was observed for the ASCUS/AGUS:LSIL ratio. Independent and consensus review confirmed 145 LSIL+ diagnoses; of these, 18% more had been detected initially on the ThinPrep slides than on the conventional smears (P = 0.041). The ThinPrep Pap Test is more accurate than the conventional Pap test and has the potential to optimize the effectiveness of primary cervical cancer screening. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bolick DR and Hellman DJ (1998) Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system. Acta Cytol 42: 209–213
Brown AD and Garber AM (1999) Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA 281: 347–353
Carpenter AB and Davey DD (1999) ThinPrep® Pap Test™: performance and biopsy follow-up in a university hospital. Cancer (Cancer Cytopathol) 87: 105–112
Corkill M, Knapp D and Hutchinson ML (1998) Improved accuracy for cervical cytology with the ThinPrep method and the endocervical brush-spatula collection procedure. Lower Genital Tract Disease 2: 12–16
Diaz-Rosario LA and Kabawat SE (1999) Performance of a fluid-based thin layer Pap smear method in the clinical setting of an independent laboratory and an out-patient screening population in New England. Arch Pathol Lab Med 123: 817–821
Dupree WB, Suprun HZ, Beckwith DG, Shane JJ and Lucente V (1998) The promise and risk of a new technology: the Lehigh Valley Hospital’s experience with liquid-based cervical cytology. Cancer 84: 202–207
Evidence Report/Technology Assessment Number 5: Evaluation of Cervical Cytology (February 1999) US Department of Health and Human Services. AHCPR Pub. No. 99–E010
Fender M, Schaffer P and Dellenbach P (1998) Peut-on et faut-il organiser le dépistage du cancer du col de l’utérus en France? [Is it possible and necessary to organise cervical cancer screening in France?]. J Gynaecol Obstet Biol Reprod 27: 683–691
Gay J, Donaldson L and Goellner J (1985) False negative results in cervical cytologic studies. Acta Cytol 29: 1043–1046
Guidos BJ and Selvaggi SM (1999) Use of the ThinPrep® Pap test™ in clinical practice. Diagn Cytopathol 20: 70–73
Hopman EH, Voorhost FJ, Kenemans P, Meijer CJLM and Helmerhorst TJM (1995) Observer agreement on interpreting colposcopic images of CIN. Gynecol Oncol 58: 206–209
Hutchinson ML, Berger BM and Farber FL (2000) Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity. Am J of Manag Care 6: 766–780
Kinney WK, Manos MM, Hurley LB and Ransley JE (1998) Where’s the high-grade neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 91: 73–76
Koss LG (1989) The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 261: 737–743
Kurman RJ and Solomon D (1994). The Bethesda system for reporting cervical/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy. Springer-Verlag: New York
Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM and Inhorn SL (1997) Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 90: 278–284
Linder J and Zahniser D (1997) The ThinPrep Pap Test: a review of clinical studies. Acta Cytol 41: 30–38
Linder J and Zahniser D (1998) ThinPrep Papanicolaou testing to reduce false-negative cervical cytology. Arch Pathol Lab Med 122: 139–144
Manos MM, Kinney WK and Hurley LB (1999) Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281: 1605–1610
National Institute for Clinical Excellence (2000). First work programme for the National Institute for Clinical Excellence,
National Institute for Clinical Excellence (2000). NICE technology appraisals: programme of results announced,
Papillo JL, Zarka MA and StJohn TK (1998) Evaluation of the ThinPrep Pap Test in clinical practice: a seven-month, 16,314-case experience in northern Vermont. Acta Cytol 42: 203–208
Roberts JM, Gurley AM, Thurloe JK, Bowditch R and Laverty CRA (1997) Evaluation of the ThinPrep Pap Test as an adjunct to the conventional Pap smear. Med J Aust 167: 466–469
Sancho-Garnier H (1998) Dépistage des cancers du col de l’utérus en France [Screening for cancers of the uterine cervix in France]. Gynécologie-Obstétrique Pratique 105: 1
Sellors JW, Nieminen P, Vesterinen E and Paavonen J (1990) Observer variability in the scoring of colpophotographs. Obstet Gynecol 76: 1006–1008
Sherman ME, Shiffman MH and Lorincz AT (1997) Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer (Cancer Cytopathology) 81: 89–97
Stenkvist B, Bergstrom R, Eklund G and Fox CH (1984) Papanicolaou smear screening and cervical cancer: what can you expect?. JAMA 252: 1423–1426
Wang T-Y, Chen H-S, Yang Y-C and Tsou M-C (1999) Comparison of fluid-based, thin-layer processing and conventional Papanicolaou methods for uterine cervical cytology. J Formos Med Assoc 98: 500–505
Weidmann C, Schaffer P and Hedelin G (1998) L’incidence du cancer du col de l’utérus régresse régulièrement en France [The incidence of cancer of the uterine cervix is regressing steadily in France]. Bull Epid Hebd 5: 17–19
Weintraub J (1997) The coming revolution in cervical cytology: a pathologist’s guide for the clinician. Références en Gynécologie Obstétrique 5: 1–6
Weintraub J and Morabia A (2000) Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer. Diagn Cytopathol 22: 52–59
Yeoh GPS, Chan KW, Lauder I and Lam MB (1999) Evaluation of the ThinPrep Papanicolaou test in clinical practice: 6-month study of 16541 cases with histological correlation in 220 cases. HKMJ 5: 233–239
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Monsonego, J., Autillo-Touati, A., Bergeron, C. et al. Liquid-based cytology for primary cervical cancer screening: a multi-centre study. Br J Cancer 84, 360–366 (2001). https://doi.org/10.1054/bjoc.2000.1588
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2000.1588
Keywords
This article is cited by
-
Optomagnetic Imaging Spectroscopy Application in Cervical Dysplasia and Cancer Detection: Comparation of Stained and Unstained Papanicolaou Smears
Journal of Medical and Biological Engineering (2017)
